Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only.
craniopharyngioma
neurocognitive
outcomes
pediatrics
quality of life
surgical technique
tumor
Journal
Journal of neurosurgery. Pediatrics
ISSN: 1933-0715
Titre abrégé: J Neurosurg Pediatr
Pays: United States
ID NLM: 101463759
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
received:
23
08
2022
accepted:
22
12
2022
medline:
3
5
2023
pubmed:
23
2
2023
entrez:
22
2
2023
Statut:
epublish
Résumé
The optimal management of pediatric craniopharyngioma patients remains controversial, shifting from radical resection (gross-total resection [GTR]) to a more conservative approach with partial resection/biopsy followed by radiotherapy (PR+RT). To the authors' knowledge, no previous studies have compared neurocognitive and quality-of-life (QOL) outcomes between the two main treatments. In this study, the authors compared changes in intellectual, adaptive, and QOL scores in children treated for craniopharyngioma with GTR and those treated with PR+RT. Patients underwent annual neurocognitive and QOL evaluations for up to 10 years posttreatment, including the Full-Scale IQ, Verbal Comprehension Index (VCI), Perceptual Reasoning Index (PRI), Working Memory Index (WMI), and Processing Speed Index (PSI). Child- and parent-reported QOL scores and adaptive behavior in different domains were assessed. General linear mixed models were used to examine change in scores over time by treatment group with adjustment for significant covariates. Scores from 43 patients treated between 2009 and 2019 (21 GTR, 22 PR+RT) were examined. Within the PR+RT group, 9 patients had intensity-modulated RT and 13 had proton beam therapy. The treatment groups were similar in sex (44% male) and age (median 7.3 years). There were no significant differences in the trajectory of intellectual functioning or QOL scale scores between the two groups. However, patients who underwent GTR exhibited significant improvement over time in overall adaptive behavior (p = 0.04) and conceptual skills (p = 0.01), which was not observed in patients treated with PR+RT. Long-term pediatric craniopharyngioma survivors treated with GTR and PR+RT have similar intellectual function and QOL. Larger studies are needed to explore small but clinically significant differences between the two groups.
Identifiants
pubmed: 36806176
doi: 10.3171/2022.12.PEDS22367
pmc: PMC10193466
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
453-462Subventions
Organisme : NCI NIH HHS
ID : K07 CA157923
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA187202
Pays : United States
Références
J Neurooncol. 2017 Aug;134(1):97-105
pubmed: 28540667
J Neurosurg. 1998 Oct;89(4):547-51
pubmed: 9761047
J Clin Endocrinol Metab. 2013 Aug;98(8):3253-62
pubmed: 23771923
J Pediatr Endocrinol Metab. 2006 Jan;19(1):11-3
pubmed: 16509523
Endocrine. 2018 Feb;59(2):364-372
pubmed: 29230635
J Neurosurg Pediatr. 2019 Jun 7;:1-10
pubmed: 31174192
Nat Rev Dis Primers. 2019 Nov 7;5(1):75
pubmed: 31699993
Horm Res. 2008;69(4):193-202
pubmed: 18204266
J Neurosurg. 2015 Sep;123(3):571-80
pubmed: 25884258
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3820-e3836
pubmed: 34086900
J Neurooncol. 2015 Oct;125(1):9-21
pubmed: 26369768
Brain Inj. 2012;26(3):270-81
pubmed: 22372414
PLoS One. 2013 Nov 05;8(11):e76562
pubmed: 24223703
Childs Nerv Syst. 2020 Feb;36(2):291-296
pubmed: 31292757
J Neurooncol. 2022 Jan;156(1):195-204
pubmed: 34846639
Neuro Oncol. 2022 Dec 1;24(12):2210-2220
pubmed: 35481829
Pediatr Blood Cancer. 2021 Sep;68(9):e29125
pubmed: 34114294
Dtsch Arztebl Int. 2019 May 3;116(18):321-328
pubmed: 31219033
Pediatr Blood Cancer. 2018 Oct;65(10):e27287
pubmed: 29932288
Dev Med Child Neurol. 2021 Aug;63(8):895
pubmed: 34018183
Childs Nerv Syst. 2021 Feb;37(2):403-410
pubmed: 32888069
J Pediatr Endocrinol Metab. 2006 Jan;19(1):15-24
pubmed: 16509524
Neurosurg Focus. 2020 Jan 1;48(1):E6
pubmed: 31896083
Neuro Oncol. 2022 Dec 1;24(12):2200-2209
pubmed: 35556133
Dev Med Child Neurol. 2021 Aug;63(8):984-990
pubmed: 33754350
Dev Med Child Neurol. 2004 Apr;46(4):220-9
pubmed: 15077699
Health Qual Life Outcomes. 2007 Jan 03;5:2
pubmed: 17201923
J Pediatr. 2014 Apr;164(4):876-881.e4
pubmed: 24507865
Neuro Oncol. 2019 Jun 10;21(6):809-818
pubmed: 30753584
Childs Nerv Syst. 2013 Feb;29(2):231-8
pubmed: 23089933
J Neurosurg Pediatr. 2021 May 28;:1-8
pubmed: 34049281